N-(2-Amino-4-trifluoromethylphenyl)morpholine, 97.0%, 500mg

N-desmethyl Enzalutamide, 25mg

Methoxypolyethylene glycols-average M.W. 2000, average M.W. 2000, 5g

Ethyl 4-bromocyclohex-3-enecarboxylate, 97%, 1g

TERT-BUTYL 3,3-DIMETHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,6-TETRAHYDROPYRIDINE-1-CARBOXYLATE, 95.0%, 100mg

4,4'-Difluoro-2,2'-bipyridine, 97.0%, 50mg

(5-morpholin-4-yl-2H-tetrazol-2-yl)acetic acid, 95.0%, 1g

4,4'-(2,2-Bis(4-methoxyphenyl)ethene-1,1-diyl)dibenzaldehyde, 95%, 250mg

HPLC column NUCLEODUR® C18 Gravity 5 µm, 150 mm, 4.6 mm, 1 Piece(s)

2-(2-Bromophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborine>98.0%(GC)(N)1g

N1-Phenylbenzene-1,4-diamine, 95.0%, 25g

2,5-Furandicarboxylic acid, 97.0%, 25g

Methylmaleic Hydrazide>98.0%(GC)25g